Shares of medical technology company Orchestra BioMed Holdings surged 49% to $5.98 after Barclays initiated coverage with an overweight rating and $16 price target. Volume was more than 652,000 shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback